Serum cholinesterase inhibition in relation to paraoxonase-1 (PON1) status among organophosphate-Exposed agricultural pesticide handlers

Environmental Health Perspectives

Volumn 117, Issue 9, 2009, Pages 1402-1408

  Hofmann, Jonathan N ^a,d   Keifer, Matthew C ^a   Furlong, Clement E ^a,b   De Roos, Anneclaire J ^a,c   Farin, Federico M ^a   Fenske, Richard A ^a   van Belle, Gerald ^a,b   Checkoway, Harvey ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Agriculture; Cholinesterase; Farmworkers; Gene environment interaction; Organophosphates; Paraoxonase; Pesticides

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; AZINPHOS METHYL; CARBARIL; CHLORPYRIFOS; CHOLINESTERASE; DIMETHOATE; MALATHION; ORGANOPHOSPHATE PESTICIDE;

ADULT; AGRICULTURAL WORKER; ARTICLE; BLOOD SAMPLING; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FOLLOW UP; GENOTYPE; HOMOZYGOTE; HUMAN; MALE; MONITORING; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; UNITED STATES;

ADOLESCENT; ADULT; AGRICULTURE; ARYLDIALKYLPHOSPHATASE; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; WASHINGTON; YOUNG ADULT;

ANIMALIA;

EID: 69949106030     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0900682     Document Type: Article

References (48)

1. Alavanja MC, Hoppin JA, Kamel F. 2004. Health effects of chronic pesticide exposure: cancer and neurotoxicity. Annu Rev Public Health 25:155-197.
2. Amitai G, Moorad D, Adani R, Doctor BP. 1998. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon. Biochem Pharmacol 56(3):293-299.
3. Battuello K, Furlong CE, Fenske RA, Austin MA, Burke W. 2004. Paraoxonase polymorphisms and susceptibility to organophosphate pesticides. In: Human Genome Epidemiology: A Scientific Foundation for Using Genetic Information to Improve Health and Prevent Disease (Khoury MJ, Little J, Burke W, eds). New York:Oxford University Press, 305-321.
4. Brophy VH, Hastings MD, Clendenning JB, Richter RJ, Jarvik GP, Furlong CE. 2001a. Polymorphisms in the human paraoxonase (PON1) promoter. Pharmacogenetics 11(1):77-84.
5. Brophy VH, Jampsa RL, Clendenning JB, McKinstry LA, Jarvik GP, Furlong CE. 2001b. Effects of 5′ regulatory-region polymorphisms on paraoxonase-gene (PON1) expression. Am J Hum Genet 68(6):1428-1436.
6. California Environmental Protection Agency. 1998. Report for the Application and Ambient Air Monitoring of Chlorpyrifos (and the Oxon Analogue) in Tulare County during Spring/Summer, 1996. Available: http://www.cdpr.ca.gov/docs/emon/pubs/tac/tacpdfs/chlrpfs.pdf [accessed 9 February 2009].
7. Cocker J, Mason HJ, Garfitt SJ, Jones K. 2002. Biological monitoring of exposure to organophosphate pesticides. Toxicol Lett 134(1-3):97-103.
8. Cole TB, Walter BJ, Shih DM, Tward AD, Lusis AJ, Timchalk C, et al. 2005. Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism. Pharmacogenet Genomics 15(8):589-598.
9. Costa LG, Cole TB, Vitalone A, Furlong CE. 2005a. Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity. Clin Chim Acta 352(1-2):37-47.
10. Costa LG, Vitalone A, Cole TB, Furlong CE. 2005b. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 69(4):541-550.
11. Dosemeci M, Alavanja MC, Rowland AS, Mage D, Zahm SH, Rothman N, et al. 2002. A quantitative approach for estimating exposure to pesticides in the Agricultural Health Study. Ann Occup Hyg 46(2):245-260.
12. Durrington PN, Mackness B, Mackness MI. 2002. The hunt for nutritional and pharmacological modulators of paraoxonase. Arterioscler Thromb Vasc Biol 22(8):1248-1250.
13. Ecobichon DJ. 2001. Toxic effects of pesticides. In: Casarett and Doull's Toxicology: The Basic Science of Poisons (Klaassen CD, ed). New York:McGraw-Hill, 763-810.
14. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. 1961. A new and rapid colorimetric determination of acetyl-cholinesterase activity. Biochem Pharmacol 7:88-95.
15. Ferre N, Camps J, Fernandez-Ballart J, Arija V, Murphy MM, Ceruelo S, et al. 2003. Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population. Clin Chem 49(9):1491-1497.
16. Furlong CE, Costa LG, Hassett C, Richter RJ, Sundstrom JA, Adler DA, et al. 1993. Human and rabbit paraoxonases: purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxification. Chem Biol Interact 87(1-3):35-48.
17. Furlong CE, Holland N, Richter RJ, Bradman A, Ho A, Eskenazi B. 2006. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet Genomics 16(3):183-190.
18. Furlong CE, Li WF, Richter RJ, Shih DM, Lusis AJ, Alleva E, et al. 2000. Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1). Neurotoxicology 21(1-2):91-100.
19. Jarvik GP, Tsai NT, McKinstry LA, Wani R, Brophy VH, Richter RJ, et al. 2002. Vitamin C and E intake is associated with increased paraoxonase activity. Arterioscler Thromb Vasc Biol 22(8):1329-1333.
20. Kamel F, Engel LS, Gladen BC, Hoppin JA, Alavanja MC, Sandler DP. 2005. Neurologic symptoms in licensed private pesticide applicators in the Agricultural Health Study. Environ Health Perspect 113:877-882.
21. Kamel F, Hoppin JA. 2004. Association of pesticide exposure with neurologic dysfunction and disease. Environ Health Perspect 112:950-958.
22. Lee BW, London L, Paulauskis J, Myers J, Christiani DC. 2003. Association between human paraoxonase gene polymorphism and chronic symptoms in pesticide-exposed workers. J Occup Environ Med 45(2):118-122.
23. Leviev I, James RW. 2000. Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations. Arterioscler Thromb Vasc Biol 20(2):516-521.
24. Li WF, Costa LG, Richter RJ, Hagen T, Shih DM, Tward A, et al. 2000. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds. Pharmacogenetics 10(9):767-779.
25. Lotti M. 2001. Clinical toxicology of anticholinesterase agents in humans. In: Handbook of Pesticide Toxicology. 2nd ed, Vol 2 (Krieger R, ed). San Diego, CA:Academic Press, 1043-1085.
26. Mackness B, Durrington P, Povey A, Thomson S, Dippnall M, Mackness M, et al. 2003. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep. Pharmacogenetics 13(2):81-88.
27. Nolan RJ, Rick DL, Freshour NL, Saunders JH. 1984. Chlorpyrifos: pharmacokinetics in human volunteers. Toxicol Appl Pharmacol 73(1):8-15.
28. Perez-Herrera N, Polanco-Minaya H, Salazar-Arredondo E, Solis-Heredia MJ, Hernandez-Ochoa I, Rojas-Garcia E, et al. 2008. PON1Q192R genetic polymorphism modifies organophosphorous pesticide effects on semen quality and DNA integrity in agricultural workers from southern Mexico. Toxicol Appl Pharmacol 230(2):261-268.
29. Quistad GB, Klintenberg R, Casida JE. 2005. Blood acylpeptide hydrolase activity is a sensitive marker for exposure to some organophosphate toxicants. Toxicol Sci 86(2):291-299.
30. Richards P, Johnson M, Ray D, Walker C. 1999. Novel protein targets for organophosphorus compounds. Chem Biol Interact 119-120:503-511.
31. Richter RJ, Furlong CE. 1999. Determination of paraoxonase (PON1) status requires more than genotyping. Pharmacogenetics 9(6):745-753.
32. Richter RJ, Jarvik GP, Furlong CE. 2009. Paraoxonase 1 (PON1) status and substrate hydrolysis. Toxicol Appl Pharmacol 235(1):1-9.
33. Rothlein J, Rohlman D, Lasarev M, Phillips J, Muniz J, McCauley L. 2006. Organophosphate pesticide exposure and neurobehavioral performance in agricultural and non-agricultural Hispanic workers. Environ Health Perspect 114:691-696.
34. SAC. 2006. Cholinesterase Monitoring of Pesticide Handlers in Agriculture: 2004-2006. Olympia, WA:Scientific Advisory Committee for Cholinesterase Monitoring. Available: http://www.lni.wa.gov/Safety/ Topics/AtoZ/Cholinesterase/files/2004-06ChESACreport.pdf [accessed 9 February 2009].
35. Searles Nielsen S, Mueller BA, De Roos AJ, Viernes HM, Farin FM, Checkoway H. 2005. Risk of brain tumors in children and susceptibility to organophosphorus insecticides: the potential role of paraoxonase (PON1). Environ Health Perspect 113:909-913.
36. Shih DM, Gu L, Xia YR, Navab M, Li WF, Hama S, et al. 1998. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature 394(6690):284-287.
37. Sidell FR, Kaminskis A. 1975. Temporal intrapersonal physiological variability of cholinesterase activity in human plasma and erythrocytes. Clin Chem 21(13):1961-1963.
38. Sozmen EY, Mackness B, Sozmen B, Durrington P, Girgin FK, Aslan L, et al. 2002. Effect of organophosphate intoxication on human serum paraoxonase. Hum Exp Toxicol 21(5):247-252.
39. Suehiro T, Nakamura T, Inoue M, Shiinoki T, Ikeda Y, Kumon Y, et al. 2000. A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression. Atherosclerosis 150(2):295-298.
40. U.S. EPA. 2000. The Use of Data on Cholinesterase Inhibition for Risk Assessments of Organophosphorous and Carbamate Pesticides. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/ pesticides/trac/science/cholin.pdf [accessed 9 February 2009].
41. U.S. EPA. 2005. Estimation of Cumulative Risk from n-Methyl-Carbamate Pesticides: Preliminary Assessment. Washington, DC:U.S. Environmental Protection Agency.
42. U.S. EPA. 2006. Organophosphorus Cumulative Risk Assessment, 2006 Update. Washington, DC:U.S. Environmental Protection Agency. Available: http://www.epa.gov/pesticides/cumulative/2006-op/op_cra_main.pdf [accessed 9 February 2009].
43. Washington State Department of Health. 2008. Pesticide Incident Reporting and Tracking Review Panel: 2007 Annual Report. Available: http://www.doh.wa.gov/ehp/Pirt/07PIRTrpt.pdf [accessed 11 May 2009].
44. WADLI. 2004. Safety Standards for Agriculture: Cholinesterase Monitoring. WAC 296-307-148. Tumwater, WA:Washington State Department of Labor and Industries.
45. WADLI (Washington State Department of Labor and Industries). 2006. Cholinesterase Monitoring for Agricultural Pesticide Handlers: Guidelines for Health Care Providers in Washington State. Available: http://www.lni.wa.gov/Safety/Topics/AtoZ/Cholinesterase/files/ ProvidersGuidelines1.pdf [accessed 9 February 2009].
46. WADLI (Washington State Department of Labor and Industries). 2007. Cholinesterase Monitoring of Pesticide Handlers in Agriculture: 2007 Final Report. Available: http://www.lni.wa.gov/Safety/Topics/AtoZ/ Cholinesterase/files/DOSH_ChE_Report07_Final_010407.pdf [accessed 9 February 2009].
47. Yuknavage KL, Fenske RA, Kalman DA, Keifer MC, Furlong CE. 1997. Simulated dermal contamination with capillary samples and field cholinesterase biomonitoring. J Toxicol Environ Health 51(1):35-55.
48. Zech R, Zurcher K. 1974. Organophosphate splitting serum enzymes in different mammals. Comp Biochem Physiol B 48(3):427-433.